Author profile

Canadian endocrinologists’ views on growth hormone replacement therapy in adult survivors of pediatric brain tumors following achievement of final height

Background Growth hormone deficiency (GHD) is frequently observed in survivors of pediatric brain tumors who were treated with high-dose cranial radiation therapy (more than 36 Gy). Almost 100% of patients treated with... Read More